Contact
Please use this form to send email to PR contact of this press release:
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
TO:
Please use this form to send email to PR contact of this press release:
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
TO: